Abstract
C1 inhibitor (C1-INH) regulates, complement, contact system, coagulation and fibrinolysis. Bleeding complications during cardiopulmonary bypass (CPB) have been described in a deficient patient. We report a 72 year old man affected with acquired C1-INH deficiency who successfully underwent CPB.
MeSH terms
-
Aged
-
Anabolic Agents / administration & dosage
-
Anabolic Agents / therapeutic use
-
Angioedema / blood
-
Angioedema / complications*
-
Angioedema / drug therapy
-
Antifibrinolytic Agents / administration & dosage
-
Antifibrinolytic Agents / therapeutic use
-
Aprotinin / therapeutic use
-
Autoimmune Diseases / blood
-
Autoimmune Diseases / complications*
-
Autoimmune Diseases / drug therapy
-
Calcium Channel Blockers / administration & dosage
-
Calcium Channel Blockers / therapeutic use
-
Cardiopulmonary Bypass*
-
Complement Activation
-
Complement C1 Inactivator Proteins / deficiency*
-
Coronary Artery Bypass
-
Hemostatics / therapeutic use
-
Heparin Antagonists / administration & dosage
-
Heparin Antagonists / therapeutic use
-
Humans
-
Laryngeal Edema / complications
-
Laryngeal Edema / drug therapy
-
Laryngeal Edema / etiology
-
Male
-
Myocardial Infarction / complications
-
Myocardial Infarction / drug therapy
-
Myocardial Infarction / surgery
-
Postoperative Complications / prevention & control
-
Protamines / administration & dosage
-
Protamines / therapeutic use
-
Recurrence
-
Stanozolol / administration & dosage
-
Stanozolol / therapeutic use
-
Tranexamic Acid / administration & dosage
-
Tranexamic Acid / therapeutic use
Substances
-
Anabolic Agents
-
Antifibrinolytic Agents
-
Calcium Channel Blockers
-
Complement C1 Inactivator Proteins
-
Hemostatics
-
Heparin Antagonists
-
Protamines
-
Stanozolol
-
Tranexamic Acid
-
Aprotinin